We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.23B
AUM Growth
+$1.6B
Cap. Flow
+$897M
Cap. Flow %
21.18%
Top 10 Hldgs %
21.32%
Holding
1,176
New
232
Increased
605
Reduced
167
Closed
168

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$84.9M
2
LU icon
Lufax Holding
LU
+$59.6M
3
BABA icon
Alibaba
BABA
+$42.6M
4
JD icon
JD.com
JD
+$41.5M
5
GRPN icon
Groupon
GRPN
+$36.4M

Top Sells

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$25.2M
2
JMIA
Jumia Technologies
JMIA
+$21.7M
3
MTCH icon
Match Group
MTCH
+$20.5M
4
FVRR icon
Fiverr
FVRR
+$15.4M
5
SFIX
Stitch Fix
SFIX
+$10.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.91%
2 Technology 23.48%
3 Communication Services 13.86%
4 Financials 4.63%
5 Real Estate 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
776
BioCryst Pharmaceuticals
BCRX
$2.4B
$30K ﹤0.01%
4,120
+2,614
+174% +$13.5K
CDXS icon
777
Codexis
CDXS
$158M
$30K ﹤0.01%
+1,380
New +$22.7K
CSTL icon
778
Castle Biosciences
CSTL
$979M
$30K ﹤0.01%
460
+292
+174% +$15.8K
GBIO
779
DELISTED
Generation Bio
GBIO
$30K ﹤0.01%
+108
New +$34.7K
GPC icon
780
Genuine Parts
GPC
$18.7B
$30K ﹤0.01%
305
+101
+50% +$9.88K
RYTM icon
781
Rhythm Pharmaceuticals
RYTM
$7.96B
$30K ﹤0.01%
1,015
+637
+169% +$16.2K
SUPN icon
782
Supernus Pharmaceuticals
SUPN
$2.77B
$30K ﹤0.01%
1,210
+758
+168% +$16.3K
ZS icon
783
Zscaler
ZS
$27.3B
$30K ﹤0.01%
155
-428
-73% -$68.1K
GDDY icon
784
GoDaddy
GDDY
$11.5B
$29K ﹤0.01%
352
+80
+29% +$6.28K
INVA icon
785
Innoviva
INVA
$1.48B
$29K ﹤0.01%
2,375
+1,511
+175% +$16.3K
IT icon
786
Gartner
IT
$11.7B
$29K ﹤0.01%
183
+13
+8% +$1.87K
MGNX icon
787
MacroGenics
MGNX
$257M
$29K ﹤0.01%
1,310
+846
+182% +$19.5K
MKL icon
788
Markel Group
MKL
$23.2B
$29K ﹤0.01%
29
-5
-15% -$4.98K
NRIX icon
789
Nurix Therapeutics
NRIX
$2.65B
$29K ﹤0.01%
+890
New +$29.5K
STX icon
790
Seagate
STX
$184B
$29K ﹤0.01%
475
-7,229
-94% -$406K
DAY
791
DELISTED
Dayforce
DAY
$29K ﹤0.01%
275
-748
-73% -$70.7K
ARQT icon
792
Arcutis Biotherapeutics
ARQT
$3.18B
$28K ﹤0.01%
+1,000
New +$24.5K
BXP icon
793
Boston Properties
BXP
$11.1B
$28K ﹤0.01%
302
+64
+27% +$5.72K
CABO icon
794
Cable One
CABO
$212M
$28K ﹤0.01%
13
-21
-62% -$41.5K
CCK icon
795
Crown Holdings
CCK
$13.1B
$28K ﹤0.01%
+280
New +$25.7K
CGNX icon
796
Cognex
CGNX
$11.3B
$28K ﹤0.01%
354
-14,236
-98% -$1.04M
CHRS icon
797
Coherus Oncology
CHRS
$196M
$28K ﹤0.01%
1,655
+1,045
+171% +$18.6K
CINF icon
798
Cincinnati Financial
CINF
$27.1B
$28K ﹤0.01%
328
+90
+38% +$7.18K
OMC icon
799
Omnicom Group
OMC
$23.4B
$28K ﹤0.01%
452
+112
+33% +$6.4K
ORIC icon
800
Oric Pharmaceuticals
ORIC
$1.4B
$28K ﹤0.01%
+840
New +$24.1K
30 31
32
33 34

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Penserra Capital Management held 1,176 positions worth $4.23B, up 61% from $2.63B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Penserra Capital Management deployed $897M of net new capital in Q4 2020, opening 232 new positions and adding to 605 existing holdings. Its largest new stake was KE Holdings: 1,278,021 shares worth $78.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Peloton Interactive, an estimated $25.2M trimmed.

  • Penserra Capital Management's largest Q4 2020 buy was KE Holdings: 1,278,021 shares worth $78.6M.
  • Penserra Capital Management added most to Alibaba in Q4 2020, an estimated $42.6M increase.
  • Penserra Capital Management's biggest Q4 2020 reduction was Peloton Interactive, cutting an estimated $25.2M.
  • Penserra Capital Management fully exited Palomar in Q4 2020, selling an estimated $6.65M.
  • Penserra Capital Management's ten largest holdings make up 21% of its $4.23B portfolio in Q4 2020.
  • Penserra Capital Management opened 232 new positions and closed 168 in Q4 2020.
  • Penserra Capital Management's portfolio value rose 61% quarter-over-quarter to $4.23B.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.